FRA:JIL (Hong Kong)
Â
Class H
€
0.25
(0%)
Jul 3
Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
ISIN : CNE100000130
Share Class Description:
FRA:JIL: Class HTotal Employee Number:
1,107Compare
Compare
Traded in other countries / regions
08049.Hong KongJIL.Germany IPO Date
2025-09-05Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1703.2 | |||||
Equity-to-Asset | 0.63 | |||||
Interest Coverage | 154.89 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.32 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2 | |||||
3-Year EBITDA Growth Rate | 8 | |||||
3-Year EPS without NRI Growth Rate | 1.3 | |||||
3-Year FCF Growth Rate | 15.6 | |||||
3-Year Book Growth Rate | 1.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.71 | |||||
9-Day RSI | 37.51 | |||||
14-Day RSI | 41.99 | |||||
3-1 Month Momentum % | 6.67 | |||||
6-1 Month Momentum % | 11.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 1.22 | |||||
Cash Ratio | 0.72 | |||||
Days Inventory | 186.52 | |||||
Days Sales Outstanding | 106.48 | |||||
Days Payable | 160.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 3.4 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.02 | |||||
Operating Margin % | 23.78 | |||||
Net Margin % | 22.05 | |||||
EBITDA Margin % | 29.48 | |||||
FCF Margin % | 33.42 | |||||
OCF Margin % | 34.8 | |||||
ROE % | 11.92 | |||||
ROA % | 7.67 | |||||
ROIC % | 11.05 | |||||
3-Year ROIIC % | 1.59 | |||||
ROC (Joel Greenblatt) % | 104.21 | |||||
ROCE % | 15.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5.92 | |||||
PE Ratio without NRI | 5.92 | |||||
Shiller PE Ratio | 6.7 | |||||
Price-to-Owner-Earnings | 3.79 | |||||
PEG Ratio | 0.88 | |||||
PS Ratio | 1.31 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.71 | |||||
Price-to-Free-Cash-Flow | 3.9 | |||||
Price-to-Operating-Cash-Flow | 3.74 | |||||
EV-to-EBIT | 1.74 | |||||
EV-to-EBITDA | 1.74 | |||||
EV-to-Revenue | 0.51 | |||||
EV-to-FCF | 1.53 | |||||
Price-to-GF-Value | 1.38 | |||||
Price-to-Projected-FCF | 0.35 | |||||
Price-to-DCF (Earnings Based) | 0.5 | |||||
Price-to-DCF (FCF Based) | 0.25 | |||||
Price-to-Median-PS-Value | 1.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.92 | |||||
Price-to-Graham-Number | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 4.96 | |||||
Earnings Yield (Greenblatt) % | 57.47 | |||||
FCF Yield % | 25.68 | |||||
Forward Rate of Return (Yacktman) % | 23.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 109.131 | ||
| EPS (TTM) (€) | 0.043 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 41.99 | ||
| 14-Day ATR (€) | 0.005923 | ||
| 20-Day SMA (€) | 0.2644 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.206 - 0.308 | ||
| Shares Outstanding (Mil) | 560.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| HKD 0.287300 Cash Dividend | 2026-06-22 | 0.29 (+0.00%) |
Show
Entries
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Frequently Asked Questions
What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(FRA:JIL)'s stock price today?
The current price of FRA:JIL is €0.25. The 52 week high of FRA:JIL is €0.31 and 52 week low is €0.21.
When is next earnings date of Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(FRA:JIL)?
The next earnings date of Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(FRA:JIL) is .
Does Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(FRA:JIL) pay dividends? If so, how much?
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd(FRA:JIL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers